Lets Cure Diabetes: A New Approach for Type 2 Diabetes

Wednesday, December 8, 2010

A New Approach for Type 2 Diabetes

A New Approach for Type 2 Diabetes - Diabetes Health Diabetes Health - Your Essential Diabetes News Source

My Account ??|??Subscribe??|??Contact Us??|??Donate Search Home

Home Charts Recipes Digital Edition TV Apps Community Kids & Teens Type 2 Issues Type 1 Issues Professional Issues Pre-Diabetes Beginners International Health Events History Camps for Kids Online Resources Dating World Diabetes Day Pets All Sections Products Product Directory Charts Syringes Insulin Pumps Meters Pens Software CGMs Books Medical ID Jewelry Lancing Devices Infusion Sets Carrying Cases Pen Needles All Sections Complications & Care Heart Care & Heart Disease Low Blood Sugar Foot Care Kidney Care (Nephropathy) Nerve Care (Neuropathy) Eye Care (Retinopathy) Hypoglycemia Unawareness Sexual Issues Geriatrics Depression Insulin Resistance Skin Care Lipid Problems Wound Care Reversing Complications All Sections Food Recipes Diets Vitamins Food News Nutrition Advice Low Carb Supplements Glycemic Index & Carb Counting Beverages Low Calorie & Low Fat Sugar & Sweeteners Desserts Herbs Dinner Lunch All Sections Columns Cartoons & eCards Personal Stories Letters to the Editor Inspiration My Own Injection Book Reviews Motivation Heroes Making a Difference CDE of the Month Doctors & Nurses Love and Diabetes After All These Years All Sections Medications Insulin Type 2 Medications Metformin Pharmacy Lantus Byetta Actos Animal Insulin Januvia Victoza Symlin Apidra Onglyza Voglibose All Sections Research Nutrition Research Islet & Pancreas Transplant Medications Research Health Research The Cure Beta Cells Other Lab Tests Artificial Pancreas New Cure Research Case Studies All Sections Fitness Exercise Weight Loss Bariatric Surgery Success Stories Amphetamines All Sections Psychology Adolescent Boys Adolescent Girls Living with Diabetes Support Groups Women's Issues Men's Issues Teenagers Insulin Omission All Sections Monitoring Blood Sugar A1c Test Noninvasive Monitors Urine Test Laboratory Tests All Sections Health Care Health Insurance Hospital Care Endocrinology Complementary Therapies Smoking CDE Physical Therapy All Sections Legal Government & Policy Discrimination Drivers License & Pilot License Politics Driving 504 Plan in School Lobbying All Sections Pregnancy Childbirth Breastfeeding Gestational Diabetes All Sections Celebrities Nick Jonas Jay Hewitt Scott Dunton Elliott Yamin All Sections About UsAbout UsPublisher's LetterAdvertisingContact UsPress RoomSubmission GuidelinesPrivacy Policy Help function fbs_click() {u=location.href;t=document.title;window.open('http://www.facebook.com/sharer.php?u='+encodeURIComponent(u)+'&t='+encodeURIComponent(t),'sharer','toolbar=0,status=0,width=626,height=436');return false;}

See What's Inside… Living His Dream of Law Enforcement: Lt. Jose Lopez Diabetes & Alcohol Diabetes and Autoimmunity Insulindependence Precious Pooch See the entire table of contents here!

View Diabetes Health Magazine For Free Online

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To ViewFree Subscription to Diabetes Health Professional

If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.

Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.

Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.

Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.

Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.

As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!

Email Address: Area of Interest: Consumer Professional How To Change Your Newsletter Email…

You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive

Then enter your new email address in the above form and click "Subscribe"

LatestPopularTop RatedLatest Medications Articles

A New Approach for Type 2 DiabetesOpen Enrollment for 2011 Medicare prescription drug and health plans begins Nov. 15thIs Correcting Low Blood Sugars Caused by Exercise Making You Fat?Exercise Often Raises Blood Glucose in Type 1 Diabetes Surgeons Create Functional Artificial Pancreatic TissueCalibra Gains FDA Clearance to Market FinesseEarly Research Reveals New Clues to Origin of DiabetesThe Cost of DiabetesPaul and Mira Sorvino Partner with sanofi-aventis to Launch Diabetes Co-Stars FDA Significantly Restricts Access to the Diabetes Drug AvandiaPopular Medications Articles

Lantus and Levemir: What's the Difference?The History of DiabetesLegal and Illegal Drugs: What Every Person With Diabetes Should Know Before They PartyCinnamon: Should It Be Taken as a Diabetes Medication?Insulin-to-Carbohydrate RatiosInsulin For Type 2 Diabetes: Who, When, And Why?Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve PainGenentech Buys $350 Million Stake in Drug Designed to Stop Autoimmune Attacks in Type 1sNew Type 2 Drugs Januvia and Byetta Offer Big BenefitsMy Insulin OverdoseHighly Recommended Medications Articles

Insulin For Type 2 Diabetes: Who, When, And Why?Lantus and Levemir: What's the Difference?The History of DiabetesTake This Test on Insulin: You May Be Smarter Than a Doctor!Insulin, Leptin, Diabetes, and Aging: Not So Strange Bedfellows"I Just Injected 46 Units of the Wrong Insulin!"My Insulin OverdoseVitamins and Supplements: Taken For Health Or Taken For A Ride?Readers Challenge Insulin Manufacturers: Help Us Avoid Near-Fatal Mistakes!Not Surprised by ACCORD Study HaltDiabetes Health Reference ChartsType 2 Meds Reference Guide (PDF)Mail Order Reference Guide (PDF)See All Charts…Medications ArchivesBrowse the Medications ArchivesSubscribe to the Medications RSS Feed

Print|Email|Share|Comments (0)Email to a Friend

Send a link to this page to your friends and colleagues.

Your Name:Your Email:Recipient's Name:Recipient's Email:Close

The pill apparently works by increasing dopamine activity in the hypothalamus, a part of the brain.

A New Approach for Type 2 DiabetesClay Wirestone
Nov 24, 2010

A new drug for type 2 diabetes started showing up in drugstores this week, according to manufacturer Santarus. The FDA-approved drug, called Cycloset, takes an distinctive -- and not well understood -- approach to reducing blood sugar levels.?The pill apparently works by increasing dopamine activity in the hypothalamus, a part of the brain. Dopamine is a brain chemical that plays a big role in people's behavior, mood, and ability to sleep. Scientists theorize that glucose intolerance and insulin resistance may in part result from abnormal activity of this chemical, and that upping dopamine activity may iron out these problems.That's the theory, at least: the drug's exact workings aren't known.? But it seems to do the trick.

Research showed that Cycloset reduced patients' A1Cs by 0.6% to 0.9% compared with a placebo (when used with other oral diabetic medication). But what about day-to-day blood glucose readings? The news is good there, too. A morning dose of the drug was shown to significantly lower blood sugars after meals -- or postprandial plasma glucose levels, in researchers' parlance.

Ralph DeFronzo, MD, chief of the diabetes division in the University of Texas Health Sciences Center, said, "Cycloset represents a new treatment for adults with type 2 diabetes. Although the mechanism by which Cycloset improves glycemic control is unknown, it contains bromocriptine mesylate, which increases dopaminergic activity in the hypothalamus.. . [It] can be prescribed for adults who are inadequately controlled with diet/exercise, metformin, sulfonylureas, or thiazolidinediones." ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?

During a randomized yearlong study, the drug was not associated with increased risk of heart attacks or other cardiovascular problems. It's not recommended for those with type 1 diabetes or suffering ketoacidosis. Another cautionary note: Scientists haven't studied how it might work in conjunction with insulin.

Santarus, a specialty biopharmaceutical company, also markets Glumetza, an extended-release metformin tablet. It's developing several other drugs, including treatments for active ulcerative colitis, travelers' diarrhea, and rheumatoid arthritis.

***

Sources:

Santarus press release?

Santarus web site?

Categories: Medications, Medications Research, Research, Type 2 Issues